 | Prelude Therapeutics Incorporat | |||
| NMS : PRLD || Location: United States | ||||
$3.870.0 (0.0%) |
0.03 M | 3.87 - 4.13 | ||
| Last Updated:America/New_York | Volume | Day range |
Short Interest
| Short Date | Short Interest |
|---|---|
| March 28, 2024 | 0.622 M |
| March 15, 2024 | 0.643 M |
| Feb. 29, 2024 | 0.619 M |
| Feb. 15, 2024 | 0.504 M |
| Jan. 31, 2024 | 0.522 M |
EPS Surprise
| Period | Estimate | Actual | Surprise |
|---|---|---|---|
| 12/31/2023 | -0.50 | -0.46 | 7.96% |
| 09/30/2023 | -0.59 | -0.45 | 24.24% |
| 06/30/2023 | -0.65 | -0.54 | 16.41% |
| 03/31/2023 | -0.70 | -0.58 | 16.99% |
| 12/31/2022 | -0.64 | -0.60 | 6.34% |
PRLD Basic Data
| Sector | Healthcare | Industry | Biotechnology |
| Shares Outstanding | 42.070M | Shares Float | 13.621M |
| Short Float | 0.622M | Market Cap | 162.81M |
| Institution ownership | 73.77% | Insider ownership | 6.926% |
| Earnings Date | 05/07/2024 BMO | Cash Per Share | ? |
| Trailing EPS | -2.02 | Forward EPS | -1.62 |